SBIO
Fund Stats as of 06/22/2017
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $28.10
Last Trade Price $28.13
NAV $28.10
NAV Change $0.14
Total Net Assets $115,199,531
Total Market Value $115,213,008
Premium/Discount(%) 0.00%
Difference ($) $0.00
Volume 49,830
Shares Outstanding 4,100,000
Expenses as of 03/31/2016
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Quarterly Scorecard 
Statutory Prospectus 
Resource Library  

Index Characteristics as of 03/31/2017, subject to change

Index Top Ten Holdings

Index Name % of Index
Exelixis Inc 4.51
Taro Pharmaceutical Industries 4.04
Ionis Pharmaceuticals Inc 4.02
Alnylam Pharmaceuticals Inc 3.73
Kite Pharma Inc 3.64
Acadia Pharamceuticals Inc 3.52
Galapagos NV-SPON ADR 3.36
Neurocrine Biosciences Inc 3.19
Bluebird Bio Inc 3.14
GW Pharmaceuticals - ADR 2.59

PMBI Drug Development Pipeline

Pre-Clinical 311
Phase I 288
Phase II 349
Phase III 152
Regulatory Filing for Approval 44
Other 13

Index Profile

Index Description Value
Number of Companies 83
Market Capitalization ($ Agg. Millions) $120,790
Company Size ($ Millions)
   Average $2,648
   Median $932
   Largest $6,303
   Smallest $53
% Weight Largest Company 4.51%
Top 10 Holdings (% Market Cap Share) 35.74%
Correlation with S&P 500® Index 0.56